Person Overview

Update
Primary:
General Partner at InterWest Partners
Past:
Vice President for Discovery Research of the Lederle Laboratories Division at American Cyanamid Company
Education:
New York University, Columbia University in the City of New York

Detailed Description

Update

Dr. Arnie Oronsky has been with InterWest's life sciences team since 1994.

He is a board member of Amplimmune, Applied Genetic Technologies Corporation (AGTC), Arcion, Drais Pharmaceuticals, Dynavax Technologies (DVAX), Integrated Diagnostics, MacroGenics, RadioRX, TESARO and USDS.

As a Ph.D. in immunology and senior lecturer at the Department of Medicine at Johns Hopkins Medical School, Arnie brings a deep understanding of medical research to finding and investing in successful life sciences companies.

Prior to joining InterWest, Arnie was vice president for discovery research of the Lederle Laboratories division of American Cyanamid Company where he directed the research for new drugs.

Arnie received a Ph.D. in immunology from Columbia University and has published more than 125 articles in scientific journals.

Experience (3)

Update

Advisory Roles (10)

Update